Back to directory
Now UrinControl of Your Health
pitch_v1_importFounded 2020
HealthcareMedical Devices
See something off about this company?
Now UrinControl of Your Health
pitch_v1_importStarling is a YC and AARP backed startup building an at-home urinalysis medical device, UrinDx, that uses advanced spectroscopy and machine learning to manage chronic health conditions. Our first product is our urinary tract infection (UTI) prevention platform, and we plan to expand our FDA clearances to Chronic Kidney Disease and Bladder Cancer in subsequent submissions. Last year, Starling's UTI prevention program received successful reimbursement from Aetna, BCBS, and Medicare during their 40 patient pilot over 12 months. Today, after securing a contract with the largest chronic care coordination partner in Urology, we are raising a seed extension of $1.5M at $11M pre, of which $500k is still available for outsiders, to support scaling our commercial launch to 2,000 patients, $1.5M ARR, with 4 Large Urology Group Partner Association sites in 2026, contracts worth over $20M ARR at scale. In addition to YC and AARP, our investors include Wellstar Health System, Innospark Ventures, Rebel Fund, Magic Fund and a confidential strategic, who is funding our current clinical trial and is a potential future acquirer.
See something off about this company?
For an adult living with a chronic health condition, accessing care, sometimes as simple as providing a urine sample, commonly involves confusion, logistical challenges, and potentially shame. These challenges may prevent a patient from getting the care they need, and can ultimately land them in the Emergency Room with delirium or sepsis.
-->Closed our 4M priced seed round as highlighted by Tech Crunch including some big names like Y-combinator, Wellstar Health System, AARP, Rebel Fund, Innospark Ventures and a Coloplast ( a $32B+ strategic and potential future acquirer) -->Validated our first predictive models in a clinical study in partnership with Stanford University -->Successful FDA registration AND Medicare reimbursement for Remote Patient Monitoring -->Launching at our first 3 customers with a pipeline of an additional 4. These customers give Starling access to over 100,000 eligible patients alone. -->We have 100% compliance. With our current physician partners, patients are using UrinDx 2-5 times a day.